Condition

Multiple Sclerosis, Relapsing-Remitting clinical trials and research

• 18Clinical trials
• 18Countries

Newest Multiple Sclerosis, Relapsing-Remitting clinical trials

All recruiting trials (18)

• Slip-and-trip motor training to reduce falls in relapsing‑remitting multiple sclerosis

  This program tests whether repeated practice with controlled slips and trips helps ambulatory adults with relapsing‑remitting multiple sclerosis learn to react better and lower their chance of falling.

  Recruiting Georgia State University · Atlanta, Georgia · NCT06919900

• Effects of Ketogenic Diet on Multiple Sclerosis

  This study is testing whether a ketogenic diet or a Mediterranean diet can help people with relapsing-remitting multiple sclerosis feel better and manage their symptoms.

  Recruiting IRCCS National Neurological Institute "C. Mondino" Foundation · Pavia · NCT06715436

• Using magnetic stimulation to reduce fatigue in multiple sclerosis

  This study is testing if a type of magnetic stimulation can help reduce fatigue in people with Relapsing-Remitting Multiple Sclerosis.

  Recruiting Danish Research Centre for Magnetic Resonance · Hvidovre, Capital Region · NCT06569550

• Treatment for Multiple Sclerosis Using Stem Cell Transplantation

  This study is testing the long-term effects of a stem cell treatment for people with active relapsing-remitting multiple sclerosis to see how it impacts their health over five years.

  Recruiting at 2 sites Amsterdam UMC, location VUmc · Amsterdam and 1 other locations · NCT06567197

• Observational study of patients with Multiple Sclerosis in Switzerland

  This study is trying to find out more about the early signs of Multiple Sclerosis and how it changes over time by looking at health data from patients in Switzerland.

  Recruiting University Hospital, Basel, Switzerland · Basel · NCT06526364

• Evaluating Ozanimod versus Fingolimod for Children with Relapsing Remitting Multiple Sclerosis

  This study is testing whether ozanimod works better than fingolimod for children and teens with relapsing remitting multiple sclerosis.

  Recruiting at 20 sites Phase 3 Bristol-Myers Squibb · Loma Linda, California and 32 other locations · NCT06408259

• Brief low-oxygen breathing to boost nerve plasticity and arm strength in MS

  This will see if brief bouts of low-oxygen breathing (acute intermittent hypoxia) can quickly improve arm and hand strength and nerve signaling in people with relapsing-remitting MS who have arm weakness.

  Recruiting Shirley Ryan AbilityLab · Chicago, Illinois · NCT06390930

• Using light stimulation to enhance vision after optic neuritis in multiple sclerosis patients

  This study is testing if light stimulation can help improve vision in people with multiple sclerosis who have had optic neuritis.

  Recruiting Technical University of Munich · Munich, Bavaria · NCT06389968

• Breathing low oxygen levels to improve strength in people with multiple sclerosis

  This study is testing if short periods of low oxygen can help people with multiple sclerosis get stronger and improve their brain's ability to control movement.

  Recruiting Shirley Ryan AbilityLab · Chicago, Illinois · NCT06276634

• Understanding biomarkers in patients with Multiple Sclerosis receiving stem cell treatment

  This study is trying to find out if certain biological markers can help predict how well stem cell treatment works for people with relapsing-remitting Multiple Sclerosis.

  Recruiting Sheffield Teaching Hospitals NHS Foundation Trust · Sheffield, England · NCT06195800

• Using the Cionic Neural Sleeve to improve mobility in people with multiple sclerosis

  This study is testing if wearing the Cionic Neural Sleeve can help people with multiple sclerosis walk better and improve their overall mobility.

  Recruiting Cionic, Inc. · Cleveland, Ohio · NCT05964829

• Improving memory in multiple sclerosis patients using brain stimulation

  This study is testing if a type of brain stimulation can help improve memory and thinking skills in people with relapsing-remitting multiple sclerosis.

  Recruiting The University of Texas at Dallas · Richardson, Texas · NCT05958381

• Comparing Rituximab and Ocrelizumab for Treating Relapsing Multiple Sclerosis

  This study is testing if rituximab works just as well as ocrelizumab for treating relapsing multiple sclerosis in adults.

  Recruiting Phase 3 Amsterdam UMC, location VUmc · Amsterdam · NCT05834855

• Assessing the effects of Clemastine Fumarate on myelin repair in MS patients

  This study is testing if a medication called Clemastine Fumarate can help repair the protective covering of nerves in people with relapsing-remitting multiple sclerosis.

  Recruiting Phase 1/2 University of California, San Francisco · San Francisco, California · NCT05359653

• Investigating risk factors for disability progression in Multiple Sclerosis

  This study is trying to find out what factors might make disability get worse in people with Multiple Sclerosis by looking at their medical history and MRI scans.

  Recruiting Cedars-Sinai Medical Center · Los Angeles, California · NCT05204459

• Examining the effects of ocrelizumab in African American and Caucasian patients with relapsing multiple sclerosis

  This study is testing how well ocrelizumab works for treating relapsing multiple sclerosis in African American and Caucasian patients to see if there are any differences in how the disease progresses.

  Recruiting Wayne State University · Detroit, Michigan · NCT04458688

• Testosterone treatment for neuroprotection and myelin repair in relapsing remitting multiple sclerosis

  This study is testing if testosterone treatment can help protect nerves and repair myelin in men with relapsing-remitting multiple sclerosis who have low testosterone levels.

  Recruiting at 5 sites Phase 2 University Hospital, Strasbourg, France · Besançon and 4 other locations · NCT03910738

• Assessing eye changes in patients with multiple sclerosis

  This study is testing how changes in the eyes of people with multiple sclerosis relate to their condition, using advanced imaging techniques to see if these changes can help us understand the disease better.

  Recruiting Medical University of Vienna · Vienna, Austria · NCT03401879

Related topics

Quick answers

How many Multiple Sclerosis, Relapsing-Remitting clinical trials are recruiting right now?

18, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 18 countries. The most sites are in United States (9 trials), Italy (2 trials), Netherlands (2 trials), Australia (1 trial), Mexico (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 2, Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →